CARDIOVASCULAR MEDICINE

Lack of clopidogrel–CYP3A4 statin interaction in patients with acute coronary syndrome

D Mukherjee, E Kline-Rogers, J Fang, K Munir, K A Eagle

University of Michigan, Ann Arbor, Michigan, USA

Correspondence to:
Correspondence to:
Dr Debabrata Mukherjee
Division of Cardiology, University of Michigan, Health System, 1500 E Medical Center Drive, Ann Arbor, Michigan 48103–0311, USA; dmukherj{at}umich.edu

Objective: To assess a clinically significant interaction between cytochrome P450 3A4 (CYP3A4) metabolised statin and clopidogrel.

Design: Prospective single centre cohort study.

Setting: Academic teaching hospital in the USA.

Patients: 1651 patients presenting with acute coronary syndromes between January 1999 and February 2003 were studied. Data on baseline demographics, co-morbidities, and in-hospital management were collected.

Main outcome measure: Association of CYP3A4 metabolised statin and clopidogrel use with in-hospital and six month mortality. The impact of the combined use of a CYP3A4 statin and clopidogrel on six month mortality and major adverse cardiac events was analysed by a risk adjusted logistic regression model.

Results: The odds ratios for six month mortality were: for CYP3A4 statin, 0.43 (95% confidence interval (CI) 0.27 to 0.71, p = 0.0009); for CYP3A4 statin plus clopidogrel, 0.36 (95% CI 0.23 to 0.60, p < 0.001); for non-CYP3A4 statin, 0.22 (95% CI 0.08 to 0.59, p = 0.002); and for non-CYP3A4 statin plus clopidogrel, 0.22 (95% CI 0.06 to 0.75, p = 0.016).

Conclusions: Use of a combination of a CYP3A4 statin plus clopidogrel was associated with lower six month mortality and morbidity in patients with acute coronary syndromes. There was no significant difference in clinical benefit between a CYP3A4 statin and a non-CYP3A4 statin when used in conjunction with clopidogrel. This suggests that the proposed interaction is probably an ex vivo phenomenon and may not be clinically relevant.

Keywords: acute coronary syndrome; clopidogrel; statin; drug-drug interaction

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Bhindi, R., Ormerod, O., Newton, J., Banning, A.P., Testa, L. (2008). Interaction between statins and clopidogrel: is there anything clinically relevant?. QJM 101: 915-925 [Abstract] [Full Text]  
• Geisler, T., Zurn, C., Paterok, M., Gohring-Frischholz, K., Bigalke, B., Stellos, K., Seizer, P., Kraemer, B. F., Dippon, J., May, A. E., Herdeg, C., Gawaz, M. (2008). Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J 29: 1635-1643 [Abstract] [Full Text]  
• Patrono, C., Baigent, C., Hirsh, J., Roth, G. (2008). Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 199S-233S [Abstract] [Full Text]  
• Angiolillo, D. J., Alfonso, F. (2007). Clopidogrel Statin Interaction: Myth or Reality?. J Am Coll Cardiol 50: 296-298 [Full Text]  
• Saw, J., Brennan, D. M., Steinhubl, S. R., Bhatt, D. L., Mak, K.-H., Fox, K., Topol, E. J., on behalf of the CHARISMA Investigators, (2007). Lack of Evidence of a Clopidogrel Statin Interaction in the CHARISMA Trial. J Am Coll Cardiol 50: 291-295 [Abstract] [Full Text]  
• Jaffe, R., Strauss, B. H. (2007). Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives. J Am Coll Cardiol 50: 119-127 [Abstract] [Full Text]  
• Burton, J. R, Burton, I., Pearson, G. J (2007). Clopidogrel-Precipitated Rhabdomyolysis in a Stable Heart Transplant Patient. The Annals of Pharmacotherapy 41: 133-137 [Abstract] [Full Text]  
• Lim, M. J., on behalf of the GRACE Investigators, , Mehta, R. H. (2005). Combined pharmacological treatment with clopidogrel and statin for patients with acute coronary syndrome: is there a survival advantage?: reply. Eur Heart J 26: 1933-1933 [Full Text]  

eLetters:

Read all eLetters

Potential Statin-Clopidogrel Interaction Requires Randomised, Prospective Study

Horst Neubauer, et al.

Online, 23 Feb 2005 [Full text]

Author's reply

Debabrata Mukherjee, et al.

Online, 1 Mar 2005 [Full text]